KR101311920B1 - Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same - Google Patents

Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same Download PDF

Info

Publication number
KR101311920B1
KR101311920B1 KR1020100131711A KR20100131711A KR101311920B1 KR 101311920 B1 KR101311920 B1 KR 101311920B1 KR 1020100131711 A KR1020100131711 A KR 1020100131711A KR 20100131711 A KR20100131711 A KR 20100131711A KR 101311920 B1 KR101311920 B1 KR 101311920B1
Authority
KR
South Korea
Prior art keywords
lactide
copolymer
poly
metal complex
biopolymer
Prior art date
Application number
KR1020100131711A
Other languages
Korean (ko)
Other versions
KR20120070236A (en
Inventor
정봉현
이창수
Original Assignee
한국생명공학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원 filed Critical 한국생명공학연구원
Priority to KR1020100131711A priority Critical patent/KR101311920B1/en
Priority to PCT/KR2011/009869 priority patent/WO2012087005A2/en
Publication of KR20120070236A publication Critical patent/KR20120070236A/en
Application granted granted Critical
Publication of KR101311920B1 publication Critical patent/KR101311920B1/en

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Abstract

The present invention relates to a fluorescent nanoparticle using a lanthanide metal complex and a method for manufacturing the same, and more particularly, to a surface of a porous silica nanoparticle coated with a biopolymer, and then to a surface of the coated biopolymer. By binding, the present invention relates to a fluorescent nanoparticle using a lanthanide metal complex having improved fluorescence stability and biocompatibility in biodiagnosis and analysis, and a method of manufacturing the same.
Fluorescent nanoparticles using the lanthanide metal complex according to the present invention have a high fluorescence intensity and a long fluorescence lifetime and biocompatibility by binding the lanthanide metal complex to the surface of the biopolymer coated silica particles. Can be effectively used.

Description

Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same}

The present invention relates to a fluorescent nanoparticle using a lanthanide metal complex and a method for manufacturing the same, and more particularly, to a surface of a porous silica nanoparticle coated with a biopolymer, and then to a surface of the coated biopolymer. By binding, the present invention relates to a fluorescent nanoparticle using a lanthanide metal complex having improved fluorescence stability and biocompatibility in biodiagnosis or analysis, and a method of manufacturing the same.

Nanoporous silica colloidal particles are well-defined nanostructure systems that self-assemble nanoscale devices into larger hierarchical structures, very complex shapes commonly found in living systems. Since the study of the first ordered mesoporous silica was reported in 1992, much research has been conducted on its synthesis, analysis and application. Nanoparticles with regularly ordered pore structure, large surface area and pore volume are known to be very useful materials for biotechnology such as delivery of drugs, enzymes, DNA, etc. The mesoporous silica nanoparticles are expected to be used as multifunctional materials such as light emission, magnetic force, cell display, and therapeutic function.

Fluorescent nanoparticles, on the other hand, are similar in size to functional biomaterials (eg proteins), so biocompatible nanoparticles can be expected to breakthrough in biological and medical applications. For example, the semiconducting quantum dots are much better than the organic light emitting materials used in conventional bio-optical imaging, and the light emission color changes depending on the size, so that these characteristics can be used to obtain various optical images. .

In addition, since binding to functional groups for targeting specific cells and tissues is easy, and light emitted is stable, it can be effectively used in cell observation or non-invasive bioimaging associated with gene expression (C. Loo, A. Lowers, et al , Nano Lett . , 5,709, 2005)

Prof. Alivisatos and UCLA Weiss from the University of Berkeley have succeeded in optically imaging mouse capillaries using biotin molecules such as biotin in the quantum dots. Two different sizes of CdSe / ZnS core / shell semiconductor quantum dots It has been reported that multicolor imaging is also possible by use (M. Bruchez Jr., et. al , Science , 281, 2013, 1998).

This research has implications for the first application of inorganic quantum dots in biotechnology. On the other hand, long-term exposure of CdSe quantum dots to UV radiation has been reported to potentially elute toxic Cd 2+ ions from quantum dots (SJ Cho, et al , Langmuir , 23, 1974, 2007). In this case, it has been reported that surface protection substances are lost and produce activated oxygen, which may cause DNA damage and apoptosis (M. Green , et. al , chem . commun , 121, 2005).

Therefore, researches on the surface treatment method for preventing such side effects have been made intensively, and coating with silica has been suggested as one method.

  Like group II-VI quantum dots, group III-V and group I-III-VI quantum dots are also used in biotechnology by using various emission regions from visible to near infrared region due to their high optical stability, good quantum efficiency and excellent chemical stability. It suggests application possibilities. In addition, since III-V and I-III-VI quantum dots do not contain toxic components such as Cd, they can be safely injected into the living body and searched and traced.

However, most semiconductor quantum dots exhibiting excellent optical properties are composed of a composition containing Cd and the like. The non-eco-friendliness and toxicity of quantum dots is one of the factors that hindered the entry of fluorescent nanoparticles into the market. Although quantum dot compositions and non-quantum dot fluorescent nanoparticles of group III-V and group I-III-VI, which are alternative quantum dot compositions that deviate from the Cd component, have been developed, group II-VI semiconductor quantum dots that still contain Cd are still being developed. It does not reach the outstanding optical characteristic which it has.

Accordingly, the present inventors have made efforts to solve the problems of the prior art, and as a result, after coating a bio-compatible biopolymer on the surface of the porous silica nanoparticles, by combining the lanthanide metal complex to the coated biopolymer to the fluorescent nanoparticles When prepared, it was confirmed that the lanthanide metal complex is stably bonded to the porous silica nanoparticles to improve fluorescence stability and biocompatibility, thereby completing the present invention.

The main object of the present invention is to provide a fluorescent nanoparticle using a lanthanide metal complex which is not only biocompatible but also has improved fluorescence stability, and a method of manufacturing the same.

In order to achieve the above object, the present invention comprises the steps of (a) coating a biopolymer on the surface of the porous silica nanoparticles; And (b) binding the lanthanide metal complex to the coated biopolymer to produce fluorescent nanoparticles.

The present invention also provides a fluorescent nanoparticle produced by the above method, characterized in that the biopolymer and the lanthanide metal complex are bonded to the surface of the porous silica nanoparticle.

The present invention also provides a method for labeling a biomaterial using fluorescent nanoparticles in which a biopolymer and a lanthanide metal complex are bonded to the surface of the porous silica nanoparticles.

Fluorescent nanoparticles using the lanthanide metal complex according to the present invention have a high fluorescence intensity and a long fluorescence lifetime and biocompatibility by binding the lanthanide metal complex to the surface of the biopolymer coated silica particles. Can be effectively used.

1 is a schematic diagram of fluorescent nanoparticles using a lanthanide metal complex according to the present invention.
2 is an absorption spectrum of FT-IR before (b) / after (a) coating the biopolymer onto porous silica nanoparticles.
3 is an optical microscope image according to the presence or absence of biopolymer coated on the surface of the porous silica nanoparticles.
Figure 4 is a graph of the measurement of the surface charge before and after the silane coupling agent treatment of the fluorescent nanoparticles using the lanthanide metal complex according to the present invention.

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In general, the nomenclature used herein is well known and commonly used in the art.

The definitions of the main terms used in the description of the present invention and the like are as follows.

As used herein, "porous silica nanoparticles" are silica nanostructures having fine pore sizes of several nanometers to several micrometers, and have a well-defined regularity of pore arrays and material properties (pore size, ratio). Surface area, surface characteristics) can be adjusted, it is also called mesoporous silica.

As used herein, "biomaterial" refers to a biologically derived material such as proteins, enzymes, antibodies, peptides, lipids, DNA, RNA and PNA.

The present invention in one aspect, (a) coating the biopolymer on the surface of the porous silica nanoparticles; And (b) bonding the coated biopolymer and the lanthanide metal complex to produce fluorescent nanoparticles.

As shown in Figure 1, the fluorescent nanoparticles according to the present invention, the biopolymer 120 on the surface of the porous silica nanoparticles in order to bond the lanthanide metal complex 130, a fluorescent material on the surface of the porous silica nanoparticles (110) ) Is coated.

In this case, the biopolymer 120 is not particularly limited as long as it is a biocompatible polymer. “Biocompatibility” refers to a material that is biocompatible as a medical material capable of performing a biological function or deriving an appropriate reaction to perform an effective function.

In the present invention, the biopolymer 120 is a polyglycolide, a copolymer of glycolide, a glycolide-lactide copolymer, a glycolide-trimethylene carbonate copolymer (Glycolide-trimethylene carbonate copolymers), polylactides (Polylactides), poly-L-lactide, poly-D-lactide, poly-DL-lactide ( Poly-DLlactide), L-lactide / DL-lactide copolymer, L-lactide / D-lactide copolymer, polylactide copolymer, lactide-trimethylene glycolide copolymer, lactide-trimethylene Carbonate copolymer, lactide / δ-valerolactone copolymer, lactide / ε-caprolactone copolymer, polydepeptide (glycine-DL-lactide copolymer) [Polydepsipeptides (glycine-DL -lactide copolymer)], polylactide / ethylene oxide copolymer, ashmytricuric 3,6-subs Asymmetrically 3,6-substituted poly-1,4-dioxane-2,5-diones, poly (3-hydroxybutylate) (( Poly (3-hydroxybutyrate), poly-3-hydroxybutylate / 3-hydroxyvalerate copolymer, poly-β-hydroxypropionate, poly- p-dioxone, poly-δ-valerolactone, poly-ε-caprolactone, copolymers thereof, or blends thereof may be exemplified, but is not limited thereto. Is poly (3-hydroxybutylate-co-3-hydroxyvalate) which is a poly (3-hydroxybutylate) or a poly-3-hydroxybutylate / 3-hydroxybarrerate copolymer.

The present invention coats the porous silica nanoparticles 110 with a biocompatible, biodegradable biopolymer 120, and thus does not have the non-eco-friendly and toxic components of the existing fluorescent nanoparticles. This lanthanide metal has the advantage of increasing fluorescence efficiency when forming coordination bonds with ligands such as biopolymers.

As such, when the biopolymer 120 is coated on the surface of the porous silica nanoparticles 110, the fluorescent nanoparticles 140 are manufactured by chemically coordinating the lanthanide metal complex 130.

The lanthanide metal complex 130 has a relatively long fluorescence time of 50 to 1000 seconds while providing spectroscopic advantages in terms of sensitivity and signal / noise ratio as well as strong luminescence properties and high light safety over a wide pH range. It is very useful in the field of optically detecting or analyzing various phenomena within.

At this time, the lanthanide metal complex is Eu (2-thenoyltrifluoroacetone) 3 2H 2 O, [Eu {4- (phenyl) -6- (2'-pyridyl) pyridine-2-carboxylate} 3 ], [Eu- ( NO 3 ) 3 (2,2'-bipyrimidine) 2 ], La (2-thenoyltrifluoroacetone) 3 2H 2 O, [La {4- (phenyl) -6- (2'-pyridyl) pyridine-2-carboxylate} 3 ], [La- (NO3) 3 (2,2'-bipyrimidine) 2 ] Tb (2-thenoyltrifluoroacetone) 3 2H 2 O, [Tb {4- (phenyl) -6- (2-pyridyl) pyridine- 2-carboxylate} 3 ] and [Tb- (NO 3 ) 3 (2,2'-bipyrimidine) 2 ].

Meanwhile, as shown in FIG. 2, the fluorescent nanoparticle 140 using the lanthanide metal complex according to the present invention further includes a step of modifying with a silane coupling agent to fix at least one functional group capable of binding to a biomaterial. It may include.

In this case, the silane coupling agent is 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropyltriethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 2- (3.4-epoxycyclohexyl) ethyltri Epoxy group-containing silane coupling agents such as methoxysilane, 3-aminopropyltrimethoxysilane, N-2- (aminoethyl) -3-aminopropylmethyldimethoxysilane, 3-triethoxysilyl-N- (1.3- (Meth) acryl-group containing silane coupling agents, such as amino group containing silane coupling agents, such as dimethylbutylidene) propylamine, 3-acryloxypropyl trimethoxysilane, and 3-methacryloxypropyl triethoxysilane, 3- Isocyanate group-containing silane coupling agents such as isocyanatepropyltriethoxysilane and mixtures thereof.

In another aspect, the present invention relates to a fluorescent nanoparticle produced by the method of any one of the above, characterized in that the biopolymer and the lanthanide metal complex are bonded to the surface of the porous silica nanoparticles.

Fluorescent nanoparticles 140 according to the present invention by using a bio-friendly biopolymer 120 to stably attach the lanthanide metal complex 130 having excellent fluorescence efficiency to the porous silica nanoparticles 110, the existing silica nanoparticles It solves the problem that it cannot be used for precise diagnosis and analysis due to the fall of fluorescent material from particle or decrease of fluorescence efficiency over time, and it keeps fine nanoparticle shape for a long time, such as bio imaging, drug delivery It may be provided for bioanalysis and is very useful because it may be used in a biosensor for optically detecting or analyzing various phenomena in a biomaterial.

In another aspect, the present invention relates to a method for labeling a biomaterial using fluorescent nanoparticles in which a biopolymer and a lanthanide metal complex are bonded to a porous silica nanoparticle surface.

Fluorescent nanoparticles using a lanthanide metal complex according to the present invention can be used for labeling a biomaterial by immobilizing one or more functional groups capable of binding to the biomaterial to the biomaterial.

In addition, the fluorescent nanoparticles using the lanthanide metal complex according to the present invention can transfer various DNA and chemicals to animal cells or skin through functional groups and the like, and can also be used for drug delivery, and biofluorescence by fluorescence. It can be used as a probe in imaging.

Example

Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these examples are for illustrative purposes only and that the scope of the present invention is not construed as being limited by these examples.

Example  1: Preparation of Fluorescent Nanoparticles

1-1: Biopolymer  Combination

5 mg of porous silica nanoparticles were dispersed in 0.5 mL poly-3-hydroxybutyrate (PHB) solution (35 mg / mL in CHCl 3 ), and allowed to stand at room temperature for about 16 hours, followed by drying by centrifugation. As a result of measurement using FT-IR to confirm that PHB is bonded to the porous silica nanoparticles, as shown in FIG. 3, strong and wide due to stretching vibration of Si-O bond at 1065 cm −1 after PHB coating Absorption bands were observed, and it was confirmed that PHB was coated on the porous silica nanoparticles by disappearing the C = O stretching vibration peak of PHB at 1723 cm −1 .

1-2: Lanthanides Metal complex  Combination

The PHB-coated porous silica nanoparticles obtained in Example 1-1 were added to an ethanol mixture (6 mg / mL) mixed with europium β-diketone (EuC), followed by oxygen and europium β-diketone of the carbonyl group of PHB. Eu was reacted for about 16 hours to form a complex. When the reaction was completed, the mixture was separated by centrifugation, washed and dried to prepare fluorescent nanoparticles. In order to measure the fluorescence of the fluorescent nanoparticles thus prepared, the presence or absence of fluorescence was measured using a fluorescence scanner (Axon / GenePix 4200 professional, USA).

As a result, as shown in Figure 4, in the case of porous silica particles not coated with PHB (a) the flow path complex was not bonded to the surface of the silica particles could not confirm the fluorescence of the europium complex (EuC), PHB coated In the case of silica particles (b), the europium complex was bonded to show red fluorescent color.

1-3: Attach functional group

To 1 mg of the fluorescent nanoparticles prepared in Example 1-2, 1 ml of APTMS (3-aminopropyltrimethoxysilane) 1% ethanol solution was added and reacted for 4 hours to modify the surface of the fluorescent nanoparticles with an amine group. Surface potential (Zeta-potential & Particle size Analyzer, ELSZ-2, Otsuka Electronics, JAPAN) was measured according to pH change in order to confirm the adhesion of amine groups to the surface of fluorescent nanoparticles.

As a result, the functionalization of the positively charged amine group on the surface was confirmed from the change in the range of 40 mV to -20 mV in the nanoparticles after APTMS surface treatment.

110: porous silica nanoparticles 120: biopolymer
130: lanthanide metal complex 140: fluorescent nanoparticles

Claims (8)

Method for producing a fluorescent nanoparticles using a lanthanide metal complex comprising the following steps:
(a) coating a biopolymer on the surface of the porous silica nanoparticles; And
(b) binding the lanthanide metal complex to the coated biopolymer to produce fluorescent nanoparticles.
The method of claim 1, wherein the biopolymer is a polyglycolide (Polyglycolide), Glycolide (Copolymers of glycolide), Glycolide-lactide copolymers (Glycolide-lactide copolymers), Glycolide-trimethylene carbonate copolymer ( Glycolide-trimethylene carbonate copolymers, Polylactides, Poly-L-lactide, Poly-D-lactide, Poly-DL-Lactide -DLlactide), L-lactide / DL-lactide copolymer, L-lactide / D-lactide copolymer, polylactide copolymer, lactide-trimethylene glycolide copolymer, lactide-trimethylene carbonate Copolymer, lactide / δ-valerolactone copolymer, lactide / ε-caprolactone copolymer, polydepeptide (glycine-DL-lactide copolymer) [Polydepsipeptides (glycine-DL-) lactide copolymer)], polylactide / ethylene oxide copolymer, ash triglycerides 3,6-subs Asymmetrically 3,6-substituted poly-1,4-dioxane-2,5-diones, poly (3-hydroxybutylate) (( Poly (3-hydroxybutyrate), poly-3-hydroxybutylate / 3-hydroxyvalerate copolymer, poly-β-hydroxypropionate, poly- p-dioxone, poly-δ-valerolactone, poly-ε-caprolactone, and a mixture thereof.
The method of claim 1, wherein the lanthanide metal complex is Eu (2-thenoyltrifluoroacetone) 3 · 2H 2 O, [Eu {4- (phenyl) -6- (2'-pyridyl) pyridine-2-carboxylate} 3 ], [Eu- (NO 3 ) 3 (2,2'-bipyrimidine) 2 ], La (2-thenoyltrifluoroacetone) 3 2H 2 O, [La {4- (phenyl) -6- (2'-pyridyl) pyridine- 2-carboxylate} 3 ], [La- (NO 3) 3 (2,2'-bipyrimidine) 2 ] Tb (2-thenoyltrifluoroacetone) 3 2H 2 O, [Tb {4- (phenyl) -6- (2 ' -pyridyl) pyridine-2-carboxylate} 3 ], [Tb- (NO 3 ) 3 (2,2'-bipyrimidine) 2 ] method for producing a fluorescent nanoparticles, characterized in that selected from the group consisting of.
The method of claim 1, wherein step (b) further comprises the step of combining the biopolymer and lanthanide metal complex to fix the biomaterial, and then modified with a silane coupling agent of the fluorescent nanoparticles Manufacturing method.
The method of claim 4, wherein the silane coupling agent is 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropyltriethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 2- (3.4-epoxy Cyclohexyl) ethyltrimethoxysilane, 3-aminopropyltrimethoxysilane, N-2- (aminoethyl) -3-aminopropylmethyldimethoxysilane, 3-triethoxysilyl-N- (1.3-dimethylpart Thilidene) propylamine, 3-acryloxypropyltrimethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-isocyanatepropyltriethoxysilane and mixtures thereof Method for producing fluorescent nanoparticles.
The method of claim 1, wherein the lanthanide metal complex of step (b) is bonded to the biopolymer by coordination bond.
Prepared by the method of any one of claims 1 to 6,
Porous silica nanoparticles;
A biopolymer coated on the surface of the porous silica nanoparticles; And
Lanthanide metal complex bonded to the biopolymer;
Fluorescent nanoparticles comprising a.
Claim 7 labeling method of a biological material using the fluorescent nanoparticles.
KR1020100131711A 2010-12-21 2010-12-21 Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same KR101311920B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020100131711A KR101311920B1 (en) 2010-12-21 2010-12-21 Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same
PCT/KR2011/009869 WO2012087005A2 (en) 2010-12-21 2011-12-20 Fluorescent nano particles using a lanthanide metal complex and method for preparing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100131711A KR101311920B1 (en) 2010-12-21 2010-12-21 Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same

Publications (2)

Publication Number Publication Date
KR20120070236A KR20120070236A (en) 2012-06-29
KR101311920B1 true KR101311920B1 (en) 2013-09-26

Family

ID=46314615

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100131711A KR101311920B1 (en) 2010-12-21 2010-12-21 Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same

Country Status (2)

Country Link
KR (1) KR101311920B1 (en)
WO (1) WO2012087005A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220128851A (en) * 2021-03-15 2022-09-22 건양대학교산학협력단 Covalently bonded fluorescent nanoparticles of mesoporous silica particles with beta-diketone europium complexes and preparation method therefore

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101423589B1 (en) * 2013-03-27 2014-07-28 주식회사 메디센서 Non-toxic Fluorescent particle including lanthanide complexes
CN103540318B (en) * 2013-10-11 2015-05-06 上海大学 Preparation method of rare earth complex grafted luminescent titanium dioxide mesoporous microsphere
KR101495194B1 (en) * 2013-11-12 2015-02-25 연세대학교 산학협력단 Sensor Containing Lanthanide Complex Structure For Detecting Cation Qualitatively And Quantitavely, And Method For Detecting Using The Same
CN104941681B (en) * 2014-03-31 2019-08-13 华东理工大学 Fluorescent sensing material and its application based on naphthalimide derivative
CN112458795B (en) * 2020-11-24 2022-05-31 陕西科技大学 Photochromic fluorescent nano-paper based on lanthanide metal organic framework and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010032942A (en) * 1997-12-09 2001-04-25 린다 에스. 스티븐슨 Block polymer processing for mesostructured inorganic oxide materials
US20070026067A1 (en) 2005-07-28 2007-02-01 Yam Noymi V Liquid formulations for controlled delivery of benzisoxazole derivatives
US20070275383A1 (en) * 2003-11-28 2007-11-29 Francis Vocanson Novel Hybrid Probes with Heightened Luminescence
JP2009509132A (en) 2005-09-16 2009-03-05 コンセホ・スペリオール・デ・インベスティガシオネス・シエンティフィカス Nanoparticle biosensor and its manufacturing method and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7317047B2 (en) * 2002-09-24 2008-01-08 E.I. Du Pont De Nemours And Company Electrically conducting organic polymer/nanoparticle composites and methods for use thereof
EP1866901B1 (en) * 2005-04-01 2012-05-16 Prysm, Inc. Display systems and devices having screens with optical fluorescent materials
GB0617480D0 (en) * 2006-09-06 2006-10-18 Univ Sheffield Novel nanoparticles
KR101695966B1 (en) * 2007-09-28 2017-01-12 나노코 테크놀로지스 리미티드 Core shell nanoparticles and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010032942A (en) * 1997-12-09 2001-04-25 린다 에스. 스티븐슨 Block polymer processing for mesostructured inorganic oxide materials
US20070275383A1 (en) * 2003-11-28 2007-11-29 Francis Vocanson Novel Hybrid Probes with Heightened Luminescence
US20070026067A1 (en) 2005-07-28 2007-02-01 Yam Noymi V Liquid formulations for controlled delivery of benzisoxazole derivatives
JP2009509132A (en) 2005-09-16 2009-03-05 コンセホ・スペリオール・デ・インベスティガシオネス・シエンティフィカス Nanoparticle biosensor and its manufacturing method and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220128851A (en) * 2021-03-15 2022-09-22 건양대학교산학협력단 Covalently bonded fluorescent nanoparticles of mesoporous silica particles with beta-diketone europium complexes and preparation method therefore
KR102525693B1 (en) 2021-03-15 2023-04-24 건양대학교 산학협력단 Preparation method of covalently bonded fluorescent nanoparticles of mesoporous silica particles with beta-diketone europium complexes

Also Published As

Publication number Publication date
WO2012087005A3 (en) 2012-09-07
WO2012087005A2 (en) 2012-06-28
KR20120070236A (en) 2012-06-29

Similar Documents

Publication Publication Date Title
Kargozar et al. Quantum dots: a review from concept to clinic
KR101311920B1 (en) Fluorescence Nanoparticle Using Lanthanide Metal Complex and Method of Preparing the Same
Santos et al. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
Sounderya et al. Use of core/shell structured nanoparticles for biomedical applications
Graf et al. A general method for the controlled embedding of nanoparticles in silica colloids
Bhat et al. ZnO nanostructures based biosensors for cancer and infectious disease applications: Perspectives, prospects and promises
Xiong et al. Stable aqueous ZnO@ polymer core− shell nanoparticles with tunable photoluminescence and their application in cell imaging
Drbohlavova et al. Quantum dots—characterization, preparation and usage in biological systems
Zhang et al. Overview of stabilizing ligands for biocompatible quantum dot nanocrystals
Yong et al. Biocompatible near‐infrared quantum dots as ultrasensitive probes for long‐term in vivo imaging applications
Muhammed et al. Growth of in situ functionalized luminescent silver nanoclusters by direct reduction and size focusing
Ghasemi et al. Quantum dot: magic nanoparticle for imaging, detection and targeting
Chen et al. Synthesis of glyconanospheres containing luminescent CdSe− ZnS quantum dots
Smith et al. Quantum dot nanocrystals for in vivo molecular and cellular imaging¶
Wang et al. ‘Green’-synthesized near-infrared PbS quantum dots with silica–PEG dual-layer coating: ultrastable and biocompatible optical probes for in vivo animal imaging
Lin et al. Highly luminescent lead sulfide nanocrystals in organic solvents and water through ligand exchange with poly (acrylic acid)
Sviridov et al. Cytotoxicity control of silicon nanoparticles by biopolymer coating and ultrasound irradiation for cancer theranostic applications
Rita Kakkar ZnO quantum dots for biomedical applications
Patel et al. Nanotechnology in healthcare: applications and challenges
Rizvi et al. Novel POSS–PCU nanocomposite material as a biocompatible coating for quantum dots
Tu et al. Silicon quantum dot nanoparticles with antifouling coatings for immunostaining on live cancer cells
Han et al. A facile synthesis of small-sized, highly photoluminescent, and monodisperse CdSeS QD/SiO2 for live cell imaging
Lu et al. Biocompatible fluorescence-enhanced ZrO2–CdTe quantum dot nanocomposite for in vitro cell imaging
Mordini et al. Luminescent gold nanoclusters for bioimaging: increasing the ligand complexity
US20100044673A1 (en) Labeling fluorescent compound

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160829

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20170824

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190404

Year of fee payment: 6

R401 Registration of restoration